Purification and initial characterization of a type beta transforming growth factor from human placenta.

Charles A. Frolik, Linda L. Dart, Chester A. Meyers, David M. Smith, Michael B. Sporn

Proceedings of the National Academy of Sciences · 1983 · 402 citations · 25 references

DOIFull text

Open access

Concepts

TL;DR

The peptide was purified from human placenta by acid/ethanol extraction, followed by gel filtration, cation exchange, and HPLC of the acid‑soluble proteins. The purified placental TGF‑β, a 23–25 kDa protein that requires EGF for anchorage‑independent growth, stimulates soft‑agar colony formation of rat kidney fibroblasts at 64–72 pg ml⁻¹ (3 pM) and is homogeneous as shown by single‑band migration and constant specific activity.

Abstract

A polypeptide transforming growth factor (TGF) that induces anchorage-dependent rat kidney fibroblasts to grow in soft agar has been isolated from human placenta and purified to homogeneity. This polypeptide is classified as a type beta TGF because it does not compete with epidermal growth factor (EGF) for membrane receptor sites but does require EGF for induction of anchorage-independent growth of indicator cells. Purification of this peptide was achieved by acid/ethanol extraction of the placenta, followed by gel filtration, cation exchange, and HPLC of the acid-soluble proteins. Homogeneity of the TGF-beta from the final column was shown by its constant specific activity and amino acid composition across the peak of soft agar colony-forming activity and by its migration as a single band at Mr 23,000-25,000 on NaDodSO4/polyacrylamide gel electrophoresis. Under reducing conditions, the protein migrated on a gel as a single band at Mr 13,000. The purified placental TGF-beta caused half-maximal growth stimulation of indicator cells in soft agar at 64-72 pg/ml (3 pM) in the presence of EGF at 2 ng/ml (0.34 nM).

References

25